[CA 125 in benign and malignant pathology of the female genital tract and neoplasms of the gastrointestinal tract].
Debiasi
D
D
Gramellini
D
D
Montagna
S
S
Calbiani
B
B
Franchini
D
D
Capocasale
E
E
Capelli
P
P
Casoni
P
P
D000230:Adenocarcinoma / Q000175:diagnosis / Q000276:immunology*; D000328:Adult; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000276:immunology*; D005831:Genital Diseases, Female / Q000175:diagnosis / Q000276:immunology*; D005833:Genital Neoplasms, Female / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000276:immunology*
D015295:Antigens, Tumor-Associated, Carbohydrate
Il CA 125 nella patologia benigna e maligna dell'apparato genitale femminile e nelle neoplasie del tratto gastro-intestinale.